The use of biologic medications for the treatment of cutaneous immune-related adverse events secondary to immune checkpoint inhibitors: A single-institution real-life study

Jade N. Young, Hannah Verma, Nour El Kashlan, Dina Poplausky, Angela J. Lamb, Emma Guttman-Yassky, Nicholas Gulati

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1-3
Number of pages3
JournalJAAD Case Reports
Volume43
DOIs
StatePublished - Jan 2024

Keywords

  • biologics
  • cirAE
  • cutaneous immune-related adverse event
  • immune checkpoint inhibitor
  • immunotherapy
  • oncodermatology

Cite this